Arlington Trust’s Insmed INSM Stock Holding History

Arlington Trust’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-44	Closed	-$4.69K	–	983
2026 Q2	$4.69K	Buy	+44	New	+$5.33K	﹤0.01%	571

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $25.3B AUM 15.9% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Arlington Trust's INSM Position: Q3 2026 in Review

Arlington Trust sold out of Insmed (INSM) in Q3 2026, closing a stake of 44 shares — an estimated $4.69K sold.

Arlington Trust first reported a position in INSM in Q2 2026 and held it in 1 quarter. The position peaked at $4.69K in Q2 2026. 342 funds tracked by Wall St. Rank hold INSM as of Q3 2026.

Arlington Trust reported no remaining Insmed position as of Q3 2026 after selling out during the quarter.
Arlington Trust sold 44 Insmed shares in Q3 2026, an estimated $4.69K.
Arlington Trust first reported a position in Insmed in Q2 2026 and held it in 1 quarter.
Arlington Trust's Insmed position peaked at $4.69K in Q2 2026.
342 funds tracked by Wall St. Rank held Insmed as of Q3 2026.

Based on Arlington Trust's 13F filing for Q3 2026, filed 20 Oct 2026.